NORTH CHICAGO, Ill.,
Nov. 15, 2017 /PRNewswire/
-- AbbVie (NYSE: ABBV) will participate in the Evercore ISI
Biopharma Catalyst/Deep Dive Conference on Wednesday, November 29, 2017. Bill Chase, executive vice president and chief
financial officer, will present at 7 a.m.
Central time.
A live audio webcast of the presentation will be accessible
through AbbVie's Investor Relations website at
investors.abbvie.com. An archived edition of the session will
be available later that day.
About AbbVie
AbbVie is a global, research-driven
biopharmaceutical company committed to developing innovative
advanced therapies for some of the world's most complex and
critical conditions. The company's mission is to use its expertise,
dedicated people and unique approach to innovation to markedly
improve treatments across four primary therapeutic areas:
immunology, oncology, virology and neuroscience. In more than
75 countries, AbbVie employees are working every day to advance
health solutions for people around the world. For more information
about AbbVie, please visit us at www.abbvie.com. Follow @abbvie on
Twitter, Facebook or LinkedIn.
View original
content:http://www.prnewswire.com/news-releases/abbvie-to-present-at-the-evercore-isi-2017-biopharma-catalystdeep-dive-conference-300555018.html
SOURCE AbbVie